Similarities between N-glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum

Journal of Nephrology

Volumn 21, Issue 1, 2008, Pages 118-126

  Iwanami, Naomi ^a   Iwase, Hitoo ^b   Takahashi, Noriko ^c,d,e   Kato, Koichi ^c,d,e   Itoh, Akihiko ^a   Takatani, Toru ^f   Makita, Shinichi ^b   Kobayashi, Yutaka ^f   Okamoto, Makito ^a   Nakamura, Shinya ^a   Hiki, Yoshiyuki ^g   Ishii, Masahiro ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e GLYENCE Co Ltd   (Japan)

^f Akebono Hospital   (Japan)

^g FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Aberrant IgA1; Asialo agalacto IgA1; High mannose type sugar chain; IgA nephropathy; IgA1 binding proteins; N Glycan; Tonsillar IgA1

Indexed keywords

FUCOSE; IMMUNOGLOBULIN A1; MANNOSE; MUTANT PROTEIN; N GLYCAN IMMUNOGLOBULIN A1; OLIGOSACCHARIDE; IMMUNOGLOBULIN A;

ARTICLE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; GLOMERULUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN STRUCTURE; TISSUE LEVEL; TONSIL; BLOOD; CHEMISTRY; GLYCOSYLATION; METABOLISM;

GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; TONSIL;

EID: 43249107276     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Baenziger J, Kornfeld S. Structure of the carbohydrate units of IgA1 immunoglobulin: Part I: composition, glycopeptide isolation, and structure of the asparagine-linked oligosaccharide unit. J Biol Chem. 1974;249:7260-7269.
2. Baenziger J, Kornfeld S. Structure of the carbohydrate units of IgA1 immunoglobulin: Part II: structure of the O-glycosidically linked oligosaccharide units. J Biol Chem. 1974;249:7270-7281.
3. Iwase H, Tanaka A, Hiki Y, et al. Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. J Chromatogr B. 1999;724:1-7.
4. Kokubo T, Hiki Y, Iwase H, et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol. 1998;9:2048-2054.
5. Oida E, Nogaki F, Kobayashi I, et al. Quantitative trait loci (QTL) analysis reveals a close linkage between the hinge region and trimeric IgA dominancy in a high IgA strain (HIGA) of ddY mice. Eur J Immunol. 2004;34:2200-2208.
6. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J Clin Invest. 1980;66:1432-1436.
7. Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal. 1990;4:115-119.
8. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complex with IgG. Kidney Int. 1997;52:509-516.
9. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J. Analysis of IgA1 O-glycan in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol. 1999;10:1763-1771.
10. Hiki Y, Tanaka A, Kokubo T, et al. Analysis of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. J Am Soc Nephrol. 1998;9:577-582.
11. Hiki Y, Kokubo T, Iwase H, et al. Under-glycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol. 1999;10:760-769.
12. Odani H, Hiki Y, Takahashi M, et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophys Res Commun. 2000;271:268-274.
13. Hiki Y, Odani M, Takahashi M, et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001;59:1077-1085.
14. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 2001;60:969-973.
15. Sano T, Hiki Y, Kokubo T, Iwase H, Endo H, Kobayashi Y. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant. 2002;17:50-56.
16. Nakamura I, Iwase H, Ohba Y, Hiki Y, Katsumata T, Kobayashi Y. Quantitative analysis of IgA1 binding protein prepared from human serum by hypoglycosylated IgA1/Sepharose affinity chromatography. J Chromatogr B. 2002;776:101-106.
17. Takatani T, Iwase H, Itoh A, et al. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy. J Nephrol. 2004;17:679-686.
18. Yan Y, Xu LX, Zhang JJ, Zhang Y, Zhao MH. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin Exp Immunol. 2006;144:17-24.
19. Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patient with IgA nephropathy. Am J Kidney Dis. 2001;38:736-743.
20. Horie A, Hiki Y, Odani H, et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis. 2003;42:486-496.
21. Itoh A, Iwase H, Takatani T, et al. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of an IgA nephropathy patient. Nephrol Dial Transplant. 2003;18:1108-1114.
22. Itoh A, Iwase H, Takatani T, et al. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients. J Nephrol. 2005;18:575-581.
23. Nishie T, Miyaishi O, Azuma H, et al. Development of immunoglobulin A nephropathy-like disease in beta-1,4-galactosyltransferase-I-deficient mice. Am J Pathol. 2007;170:447-456.
24. Marquina R, Diez MA, Lopez-Hoyos M, et al. Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic mice. J Immunol. 2004;172:7177-7185.
25. Mattu TS, Pleass RJ, Willis AC, et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem. 1998;273:2260-2272.
26. Royle L, Roos A, Harvey DJ, et al. Secretory IgA N- and O-Glycans provide a link between the innate and adaptive immune systems. J Biol Chem. 2003;278:20140-20153.
27. Takahashi N, Nakagawa H, Fujikawa K, Kawamura Y, Tomiya N. Three-dimensional elution mapping of pyridylaminated N-linked neutral and sialyl oligosaccharides. Anal Biochem. 1995;226:139-146.
28. Takahashi N, Kato K. GALAXY (Glycoanalysis by the Three Axes of MS and Chromatography): a web application that assists structural analyses of N-glycans. Trends Glycosci Glycotechnol. 2003;15:235-251.
29. Tomiya N, Awaya J, Kurono M, Endo S, Arata Y, Takahashi N. Analyses of N-linked oligosaccharides using a two-dimensional mapping technique. Anal Biochem. 1988;171:73-90.
30. Nakagawa H, Kawamura Y, Kato K, Shimada I, Arata Y, Takahashi N. Identification of neutral and sialyl N-linked oligosaccharide structures from human serum glycoproteins using three kinds of high-performance liquid chromatography. Anal Biochem. 1995;226:130-138.
31. Iwase H, Tanaka A, Hiki Y, et al. Abundance of Galβ1,3GalNAc in O-linked oligosaccharide on hinge region of polymerized IgA1 and heat-aggregated IgA1 from normal human serum. J Biochem. 1996;120:92-97.
32. Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG. IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci U S A. 1982;79:6229-6231.
33. Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17:1724-1734.
34. Tanaka A, Iwase H, Hiki Y, et al. Evidence for a site specific fucosylation on N-linked oligosaccharide of immunoglobulin A1 from normal human serum. Glycoconj J. 1998;15:995-1000.
35. Block TM, Comunale MA, Lowman M, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci U S A. 2005;102:779-784.
36. Noda K, Miyoshi E, Gu J, et al. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Res. 2003;63:6282-6289.
37. Harper SJ, Allen AC, Bene MC, et al. Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol. 1995;101:442-448.
38. Tokuda M, Shimizu J, Sugiyama N, et al. Direct evidence of the production of IgA by tonsillar lymphocytes and the binding of IgA to the glomerular mesangium of IgA nephropathy patients. Acta Otolaryngol Suppl. 1996;523:182-184.